ID   HEK293-ARV7-PSA-E/P-LUC
AC   CVCL_F0L6
RX   PubMed=24740322;
CC   Characteristics: Transfected with both a pcDNA3.1-AR-V7 plasmid and a PSA/e P-LUC plasmid where theluciferase gene expression is driven by the PSA promoter and enhancer (PubMed=24740322).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:644; AR (Note=Isoform ARv7).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=24740322; DOI=10.1158/1078-0432.CCR-13-3296; PMCID=PMC4058390;
RA   Liu, Cheng-Fei
RA   Lou, Wei
RA   Zhu, Ye-Zi
RA   Nadiminty, Nagalakshmi
RA   Schwartz, Chad T.
RA   Evans, Christopher P.
RA   Gao, Allen C.
RT   "Niclosamide inhibits androgen receptor variants expression and
RT   overcomes enzalutamide resistance in castration-resistant prostate
RT   cancer.";
RL   Clin. Cancer Res. 20:3198-3210(2014).
//